EMEA Presenting at the 74th session of the World Health Organisation Committee for Europe
EMEA News for October 2024
In 2023 the European ME Alliance received ‘
official Non-State Actor accreditation’ status
from WHO’s Regional Office for Europe during WHO Europe’s 73rd Regional Committee Meeting (RC73).
This status allows EMEA to participate in WHO Europe Regional Meetings and to make official statements on agenda topics of interest.
EMEA aims to use this platform to improve awareness, recognition, and action for Myalgic Encephalomyelitis (ME) across
WHO Europe’s 53 member states.
In October, health ministers and high-level delegates from the 53 Member States of the WHO European Region, as well as representatives of partner organizations and civil society, will meet in Copenhagen, Denmark, for the 74th session of the WHO Regional Committee for Europe (#RCP74CPH).
EMEA will be presenting at the session and issuing statements concerning ME.
Our aim is to raise awareness with WHO and its Member States about ME and to call for a comprehensive and well-funded European strategy.
WHO Europe is also organising a meeting with Non-State Actors, such as EMEA, the day before the #RCP74CPH.
For this meeting, we submitted 5 short videos on the topic of why and how engagement with WHO Europe is meaningful to EMEA.
We shall be posting news about the statements that we deliver during the course of the meeting.
A Collaborative Approach to ME
EMEA will be joined by representatives from the European ME Research Group (EMERG) - and the associated European ME Clinicians Council (EMECC) -
and Young EMERG (the young and early career researcher network formed with EMERG).
EMEA Denmark will be present to discuss ME in Denmark.
We are very pleased that Johanna Rohrhofer from
Dr Eva Untersmayr's group in Vienna will be present at the
congress as part of the EMEA
team and representing Young EMERG.
EMEA/EMERG/Young EMERG Meeting with WHO Europe Director Dr Hans Kluge
Prior to #RCP74CPH EMEA met directly with Dr Hans Kluge, WHO Regional Director for Europe, to discuss ME
and EMEA's plans and strategy.
EMEA will also discuss collaborative projects with WHO.
At the meeting, arranged at EMEA's request, we demonstrated EMEA's work in creating collaborative environment
between patients, researcher and clinicians.
EMEA was joined by Dr Jesper Mehlsen, representing the European ME Research Group (EMERG)
and the associated European ME Clinicians Council (EMECC) -
and Johanna represented Young EMERG (the young and early career researcher network formed with EMERG).
As the meeting was in Copenhagen then host EMEA Denmark was represented by Catherin Engsig.
Click image above to see Tweet from Dr Kluge
Further Reading:
- WHO Europe Message for International ME Conference Week Delegates
- EMEA Presenting at the 74th session of the World Health Organisation Committee for Europe
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item discussing the State of Health in the WHO European Region
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item 8 European regional action framework for behavioural and cultural insights for equitable health, 2022–2027
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item 9 Framework for resilient and sustainable health systems in the WHO European Region 2025–2030
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item 12 Harnessing innovation for public health in the WHO European Region 2025–2030: preparing for a new strategy
